The Argonaute protein family. Genome Biol. Portnoy, V. Small RNA and transcriptional upregulation. Wiley Interdiscip. RNA 2 , — Place, R. MicroRNA induces expression of genes with complementary promoter sequences. Natl Acad. USA , — Vasudevan, S. Switching from repression to activation: microRNAs can up-regulate translation. Science , — Suzuki, H. Emerging complexity of microRNA generation cascades.
Cell 44 , — Esquela-Kerscher, A. Oncomirs—microRNAs with a role in cancer. Cancer 6 , — Heneghan, H. MicroRNAs as novel biomarkers for breast cancer. Stroun, M. Acta , — Okada, H. MicroRNAs in immune regulation--opportunities for cancer immunotherapy. Ha, T. The role of microRNAs in regulatory T cells and in the immune response. Immune Netw. Toffanin, S. Pegtel, D. Functional delivery of viral miRNAs via exosomes.
Valadi, H. Vickers, K. Lipid-based carriers of microRNAs and intercellular communication. Skog, J. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Lu, J. MicroRNA expression profiles classify human cancers. Nature , — Volinia, S. A microRNA expression signature of human solid tumors defines cancer gene targets. Yu, S. MicroRNA signature predicts survival and relapse in lung cancer. Figures and Tables. Paper Mentions. Conditions Breast Cancer Intervention Drug. MicroRNAs are optimal biomarkers owing to high stability under storage and handling conditions and their presence in blood, urine and other body fluids.
Please check your e-mails to validate your e-mail address. To reset your password, enter your e-mail address or your user ID you registered with. You will be sent an e-mail containing a link to reset your password. A link to reset your password has been sent to your e-mail address. Follow the instructions and try to log in again.
Nishida N 2 ,. Calin GA 2 ,. Search articles by 'Klaus Pantel'. Pantel K 1. Affiliations 2 authors 1. Share this article Share with email Share with twitter Share with linkedin Share with facebook. In this regard, much effort has been made to find informative, blood-based biomarkers for patients with cancer. Owing to their attributes-which are specifically modulated by the tumour-circulating cell-free microRNAs found in the peripheral blood of patients with cancer may provide insights into the biology of the tumour and the effects of therapeutic interventions.
Separation of specific initiation factors involved in the translation of myosin and myoglobin messenger RNAs and the isolation of a new RNA involved in translation. Kanemaru, H. The circulating microRNA level in patients with malignant melanoma as a new tumor marker. Kawaguchi, T. Clinical impact of circulating miR in plasma of patients with pancreatic cancer.
Komatsu, S. Plasma microRNA profiles: identification of miR as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Konishi, H. Lages, E. Lan, H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
Larrea, E. New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies. Laterza, O. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Le, H. Evaluation of dynamic change of serum miR and miR in pre- and post-operative lung carcinoma patients. Leva, G. Li, W. MicroRNA as a biomarker for early diagnosis and recurrence of non-small cell lung cancer. PLoS One e Lian, F. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lou, N. Since ovarian cancer develops asymptomatically, it is often diagnosed at an advanced and incurable stage. Date: Mar.Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI: Efficient patient management relies on early diagnosis of disease and monitoring of treatment. In this regard, much effort has free sunday crossword puzzles to print made to find informative, blood-based biomarkers for patients with cancer. Owing to their attributes—which are specifically modulated by the tumour—circulating cell-free microRNAs found in the peripheral blood of patients with cancer may provide insights into the biology of the relegance and the effects of therapeutic interventions. View on Nature. Save to Library. Create Clinical relevance of circulating cell free micrornas in cancer. Launch Research Feed. Share This Paper. Figures, Tables, and Topics from this paper. Figures and Tables. Paper Mentions. Conditions Clinical relevance of circulating cell free micrornas in cancer Cancer Intervention Drug. Citations Microtnas citing this paper. Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? Taylor Biology, Medicine Biomedicines The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer Heidi Schwarzenbach Medicine, Biology Expert review of molecular diagnostics References Publications referenced by this paper. Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer Samir M. HanashClinical relevance of circulating cell free micrornas in cancer S. PritchardEvan M. MitchellRachael K. Circulating tumor cells as therapy-related biomarkers in cancer patients Tobias M. Clinical Relevance of Circulating Cell-Free microRNAs in Cancer. Nat Rev Clin Oncol. Mar;11(3) doi: Clinical Relevance of Circulating Cell-Free microRNAs in Ovarian Cancer. Mol Cancer. Jun 24;15(1) doi: /s Owing to their attributes-which are specifically modulated by the tumour-circulating cell-free microRNAs found in the peripheral blood of patients with cancer may. This review summarizes the current knowledge regarding the potential clinical relevance of circulating cell-free miRNA for ovarian cancer diagnosis, prognosis,. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients. Schwarzenbach H. Published data revealed a potential of circulating miRNA to become a tool Clinical relevance of circulating cell-free microRNAs in cancer. Title: Clinical relevance of circulating cell-free microRNAs in cancer. Author(s): Heidi Schwarzenbach, Naohiro Nishida, George A. Calin, and Klaus Pantel. Owing to their attributes—which are specifically modulated by the tumour—circulating cell-free microRNAs found in the peripheral blood of patients with cancer. Although ovarian cancer is highly responsive to the initial treatment by platinum- and taxane-based chemotherapies, subsequent relapses and repeated treatments using these cytotoxic chemotherapies eventually result in acquired resistance to the treatments. Zhang, H. Ryan, B. MiR is known to have a high endothelial cell EC specificity and involved in EC proliferation, migration, survival, and in the regulation of blood vessel integrity [ 87 , 88 ], indicating that the circulating level of this miRNA may reflect the response to bevacizumab. Lower concentrations of circulating plasma miRb-5p were associated with worse PFS, suggesting its potential as a novel biomarker of therapeutic response [ 84 ]. Received : 07 February Salivary microRNAs as promising biomarkers for detection of esophageal cancer. J Cancer Res Clin Oncol. J Dermatol Sci. Microparticles: protagonists of a novel communication network for intercellular information exchange. Comprehensive analysis of microRNAs in breast cancer. Switching from repression to activation: microRNAs can up-regulate translation. They are encapsulated by membrane-enclosed vesicles such as exosomes and microvesicles, or bound to carrier protein or lipids such as Argonaute2 Ago2 and HDL. The widespread regulation of microRNA biogenesis, function and decay.